Sri Jay Pharma Exim Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 22-04-2024
- Paid Up Capital ₹ 0.10 M
as on 22-04-2024
- Company Age 20 Year, 3 Months
- Last Filing with ROC 31 Mar 2017
- Revenue %
(FY 2017)
- Profit -3594.84%
(FY 2017)
- Net Worth -114.74%
(FY 2017)
- Total Assets -5.00%
(FY 2017)
About Sri Jay Pharma Exim
- CIN/LLPIN
U51397MH2004PTC148692
- Company No.
148692
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Sep 2004
- Date of AGM
29 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc-Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sri Jay Pharma Exim?
Board Members(0)
| Name | Designation | Appointment Date | Status |
|---|
Financial Performance of Sri Jay Pharma Exim.
Sri Jay Pharma Exim Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 3594.84% decrease in profit. The company's net worth observed a substantial decline by a decrease of 114.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sri Jay Pharma Exim?
In 2017, Sri Jay Pharma Exim had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sri Jay Pharma Exim?
Unlock and access historical data on people associated with Sri Jay Pharma Exim, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Jay Pharma Exim, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Jay Pharma Exim's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
